Shares of Iridium Communications (IRDM) have gained 2.4% over the past four weeks to close the last trading session at $25.17, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $38.33 indicates a potential upside of 52.3%.The mean estimate comprises six short-term price targets with a standard deviation of $7.23. While the lowest estimate of $25 indicates a 0.7% decline from the c ...

Oatly Group AB Sponsored ADR (OTLY) closed the last trading session at $10.74, gaining 20.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $18.31 indicates a 70.5% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $10.72. While the lowest estimate of $10 indicates a 6.9% decline from the current price level, the most optimist ...

Veren (VRN) closed the last trading session at $5.92, gaining 7.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $7.99 indicates a 35% upside potential.The average comprises 10 short-term price targets ranging from a low of $6.60 to a high of $9.75, with a standard deviation of $1.09. While the lowest estimate indicates an increase of 11.5% from the current price level, the most ...

Stagwell (STGW) closed the last trading session at $5.62, gaining 5.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $8.88 indicates a 58% upside potential.The average comprises eight short-term price targets ranging from a low of $7.25 to a high of $10, with a standard deviation of $1.10. While the lowest estimate indicates an increase of 29% from the current price level, the mo ...

Group 1 - iTeos Therapeutics, Inc. (ITOS) shares have increased by 31.6% over the past four weeks, closing at $7.50, with a mean price target of $23.33 indicating a potential upside of 211.1% [1] - The average price targets from analysts range from a low of $15 to a high of $47, with a standard deviation of $12.21, suggesting a high degree of variability in estimates [2] - Analysts show strong agreement on ITOS's ability to report better earnings than previously predicted, which supports the potential for stock upside [4][11] Group 2 - Recent revisions in earnings estimates for ITOS have shown two estimates moving higher and one lower, resulting in a 9.4% increase in the Zacks Consensus Estimate [12] - ITOS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13] - While consensus price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [13]

Group 1 - Trupanion (TRUP) closed at $36.44, with a 4.1% gain over the past four weeks, and a mean price target of $54.75 indicating a 50.3% upside potential [1] - The average price targets range from a low of $41 to a high of $65, with a standard deviation of $10.66, suggesting a variability in analyst estimates [2] - Analysts show strong agreement on Trupanion's ability to report better earnings, with a positive trend in earnings estimate revisions indicating potential upside [4][11] Group 2 - Over the last 30 days, the Zacks Consensus Estimate for Trupanion's current year earnings has increased by 64.3%, with two estimates moving higher and no negative revisions [12] - Trupanion holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [10][13]

Core Viewpoint - Under Armour (UAA) shows potential for significant upside, with a mean price target of $8.47 indicating a 46% increase from the current price of $5.80 [1] Price Targets and Estimates - The mean estimate consists of 15 short-term price targets with a standard deviation of $2.97, indicating variability among analysts [2] - The lowest estimate is $4, suggesting a 31% decline, while the highest estimate predicts a surge of 158.6% to $15 [2] - Analysts' price targets are often questioned for their reliability, as they may mislead investors rather than provide accurate guidance [3][7] Earnings Estimates - Analysts are optimistic about UAA's earnings, with a consensus indicating better-than-previously estimated earnings [4] - A positive trend in earnings estimate revisions has historically correlated with stock price movements, suggesting potential upside [11] - Over the last 30 days, one estimate has increased, leading to a 0.4% rise in the Zacks Consensus Estimate for the current year [12] Zacks Rank and Investment Potential - UAA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While the consensus price target may not be a reliable indicator of the extent of UAA's potential gains, it does provide a directional guide for price movement [13]

Shares of Celestica (CLS) have gained 28.9% over the past four weeks to close the last trading session at $89.21, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $120 indicates a potential upside of 34.5%.The average comprises 10 short-term price targets ranging from a low of $95 to a high of $150, with a standard deviation of $13.85. While the lowest estimate indicates an incre ...

Rambus (RMBS) closed the last trading session at $48.88, gaining 5.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $72.25 indicates a 47.8% upside potential.The average comprises eight short-term price targets ranging from a low of $55 to a high of $90, with a standard deviation of $9.97. While the lowest estimate indicates an increase of 12.5% from the current price level, the ...

Adherex Technologies Inc. (FENC) closed the last trading session at $6.19, gaining 11.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $13.20 indicates an 113.3% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $2.05. While the lowest estimate of $10 indicates a 61.6% increase from the current price level, the most optimistic ...